UCHENNA REVELS: Open Payments
NPI 1497065197 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 64 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,587
Food & beverage: $1,587
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $442 |
| Teva Pharmaceuticals USA, Inc. | 20 | $258 |
| Lundbeck LLC | 7 | $202 |
| Neurocrine BioSciences, Inc. | 7 | $198 |
| Janssen Pharmaceuticals, Inc | 6 | $150 |
| Otsuka America Pharmaceutical, Inc. | 5 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $89 |
| ABBVIE INC. | 2 | $53 |
| Braeburn Inc. | 1 | $43 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
Products named: ABILIFY ASIMTUFII, UZEDY, INGREZZA, VIVITROL, INVEGA SUSTENNA, LYBALVI, ARISTADA, COBENFY.
Industry payments across NY — which companies pay providers there.
